Mommy-Baby Treatment for Perinatal Depression
Status: | Active, not recruiting |
---|---|
Conditions: | Depression, Depression, Major Depression Disorder (MDD), Women's Studies |
Therapuetic Areas: | Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Reproductive |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | November 2012 |
End Date: | October 2016 |
Perinatal Depression: Dyadic-IPT to Improve Health of Mother and Baby
Perinatal depression is a major public health problem, affecting 15% of women during
pregnancy through the postpartum period, with adverse consequences for the mother, the
fetus, the infant, and the family. Despite increasing evidence of the importance of this
critical risk interval, little research has investigated the effects of depression treatment
during pregnancy on infant outcomes. The purpose of this study is to test the feasibility,
acceptability, and effectiveness of a new intervention, Interpersonal psychotherapy for the
mother-infant dyad (IPT-Dyad). This intervention begins during pregnancy and continues with
the mother and infant until one year postpartum. The investigators hypothesize that IPT-Dyad
will be better than treatment as usual in reducing depressive symptoms, improving
psychosocial functioning,increasing parenting self-efficacy, improving infant emotional
development, and enhancing mother-infant relationship quality.
pregnancy through the postpartum period, with adverse consequences for the mother, the
fetus, the infant, and the family. Despite increasing evidence of the importance of this
critical risk interval, little research has investigated the effects of depression treatment
during pregnancy on infant outcomes. The purpose of this study is to test the feasibility,
acceptability, and effectiveness of a new intervention, Interpersonal psychotherapy for the
mother-infant dyad (IPT-Dyad). This intervention begins during pregnancy and continues with
the mother and infant until one year postpartum. The investigators hypothesize that IPT-Dyad
will be better than treatment as usual in reducing depressive symptoms, improving
psychosocial functioning,increasing parenting self-efficacy, improving infant emotional
development, and enhancing mother-infant relationship quality.
Inclusion Criteria:
- Pregnant women
- 18 years and older
- between 12 and 30 weeks gestation
- Score greater than or equal to 13 on Edinburgh Depression Scale
- Structured Clinical Interview (SCID-IV) diagnosis of Major Depressive Disorder,
dysthymia, or Depressive Disorder, Not otherwise Specified
- English Speaking
Exclusion Criteria:
- Substance abuse or dependence in past 3 months
- Active suicidal or homicidal ideation
- Bipolar disorder, psychotic disorder
- unstable medical condition or other medical/obstetrical complication
- Evidence of severe intimate partner violence
- Ongoing psychosocial or pharmacotherapy for depression
We found this trial at
1
site
Click here to add this to my saved trials